This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Circle CardiovascularImaging has announced that Erkan Akyuz has been appointed Chief Executive Officer to succeed Circle co-founder and CEO Greg Ogrodnick. The announcement from the company, based in Canadian and founded in 2007, offered that Akyuz is joining Circle during a period of accelerated growth and product innovation.
June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific Sessions, June 14-26, at the Oregon Convention Center in Portland, OR. The Program Chair for ASE 2024 is Federico Asch, MD, FASE, MedStar Health and Georgetown University (Wash., Kerber Ethics/Humanitarian Lecturer.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
tim.hodson Thu, 12/05/2024 - 11:59 Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 million. Cleerly’s pioneering approach to advanced cardiovascularimaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.
tim.hodson Tue, 06/11/2024 - 17:21 On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." Omer Schalit–Cohen , chief product officer at Optum’s Healthcare Enterprising Imaging business unit, will be the presenter.
We’re excited to collaborate with Medis Medical Imaging to add innovative, non-invasive, image-based QFR to our portfolio of offerings around our Allia IGS platform to streamline the experience for clinicians and help us to deliver on our vision for the future image-guided therapy.” Accessed May 2024.
25, 2024 in the European Heart Journal CardiovascularImaging. 25, 2024 in the European Heart Journal CardiovascularImaging 1. 25, 2024 in the European Heart Journal CardiovascularImaging 1. In Press European Heart Journal CV Imag2024.This James Min, M.D.
June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual Scientific Meeting, SCCT24, “At the heart of it,” to be held July 18-21, in Washington, DC. AMA PRA Category 1 Credits; in addition, SCCT24 program planners note that 13.75 for all attendees. 3:00 p.m. . - 5:00 p.m.,
The FDA updated its healthcare AI database last week, increasing its list of AI-enabled clearances to a whopping 950 medical devices, while highlighting some interesting trends in cardiovascular AI. Cardiovascular AI’s 19 clearances in H1 2024 also puts the segment on pace to eclipse any previous year (previously 30, 24, 21, 20, 22, 15).
milla1cf Tue, 04/23/2024 - 16:03 April 23, 2024 — CDL Nuclear Technologies , a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer.
Cardiovascular AI maintains a (distant) second largest share of FDA-cleared AI products, with 10% of total clearances (90), well below radiology’s 76% share (671). Cardiovascular AI actually makes up a larger 17.4% FFRCT, coronary plaque, etc). in 2020-2022, and 13.5% since the start of 2023.
As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 billion by 2029, growing at a CAGR of 5.86% in the forecast period (2024-2029), according to a new report released by Mordor Intelligence. billion, and expected to reach $3.18 Technology advancements.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e016409, February 1, 2024. Innovations in cardiac imaging have fundamentally advanced the understanding and treatment of cardiovascular disease.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e015496, February 1, 2024. Therefore, innovative solutions are needed to optimize health care and address cardiovascular health disparities in rural areas.
tim.hodson Tue, 06/11/2024 - 17:21 On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." Omer Schalit–Cohen , chief product officer at Optum’s Healthcare Enterprising Imaging business unit, will be the presenter.
tim.hodson Thu, 02/22/2024 - 11:09 On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." Omer Schalit–Cohen , chief product officer at Optum’s Healthcare Enterprising Imaging business unit, will be the presenter.
tim.hodson Thu, 02/22/2024 - 11:09 On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." Omer Schalit–Cohen , chief product officer at Optum’s Healthcare Enterprising Imaging business unit, will be the presenter.
Image courtesy: Abbott christine.book Tue, 04/02/2024 - 09:36 April 2, 2024 — Abbott announced that the U.S. The MHIF Imaging Core Lab, led by João Cavalcante, MD , director of the CardiovascularImaging Research Center at MHIF , provided advanced cardiac imaging analysis for the TRILUMINATE Pivotal trial.
Renowned for his work in enhancing healthcare, Krumholz has helped shape modern cardiology by applying science in digital innovations, furthering equity, advancing patient-centric research and clinical care and fostering integrity in medical research. In addition, he co-founded medRxiv , a leading preprint server for clinical medicine.
Circulation, Volume 150, Issue 23 , Page 1885-1897, December 3, 2024. Conventional forms of noninvasive cardiovascularimaging that evaluate morphology, function, flow, and metabolism play a vital role in individual treatment decisions, often based on guidelines.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content